Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer (IES)

This study has been completed.
Sponsor:
Collaborator:
International Collaborative Cancer Group (ICCG)
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00038467
First received: May 31, 2002
Last updated: May 9, 2013
Last verified: May 2013
  Purpose

To compare the sequential administration of exemestane with administration of further tamoxifen until 5 years in postmenopausal women with operable breast cancer who have already received 2-3 years of adjuvant tamoxifen, in terms of disease-free survival (DFS), overall survival (OS), incidence of contralateral breast cancer and long-term tolerability.


Condition Intervention Phase
Breast Neoplasms
Drug: Tamoxifen
Drug: Exemestane
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Randomized Double-Blind Trial In Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen For 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen

Resource links provided by NLM:


Further study details as provided by Pfizer:

Primary Outcome Measures:
  • Disease Free Survival (DFS) [ Time Frame: June 2003, February 2006, December 2009, February 2013 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Overall survival (OS) [ Time Frame: June 2003, February 2006, December 2009, February 2013 ] [ Designated as safety issue: No ]
  • Incidence of second breast cancer (in contralateral breast) [ Time Frame: June 2003, February 2006, December 2009, February 2013 ] [ Designated as safety issue: No ]
  • Long term tolerability of the regimens [ Time Frame: February 2006 ] [ Designated as safety issue: Yes ]

Enrollment: 4738
Study Start Date: February 1998
Study Completion Date: March 2013
Primary Completion Date: June 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: B Drug: Tamoxifen
Tamoxifen 20 mg/day tablets administered p.o. for a period ranging from 2.5 to 3 years.
Experimental: A Drug: Exemestane
Exemestane 25 mg/day tablets administered p.o. for a period ranging from 2.5 to 3 years.

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • postmenopausal women with histologically or cytologically confirmed primary breast adenocarcinoma, receiving tamoxifen and have been treated with tamoxifen continuously for between 2 and 3 years and one month, and still free of disease

Exclusion Criteria:

  • unresectable breast cancer
  • ER negative primary tumor
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00038467

  Hide Study Locations
Locations
United States, Alabama
Pfizer Investigational Site
Birmingham, Alabama, United States, 35235
Pfizer Investigational Site
Birmingham, Alabama, United States, 35213
Pfizer Investigational Site
Birmingham, Alabama, United States, 35205
United States, Arizona
Pfizer Investigational Site
Green Valley, Arizona, United States, 85614
Pfizer Investigational Site
Green Velley, Arizona, United States, 85614
Pfizer Investigational Site
Tucson, Arizona, United States, 85715
Pfizer Investigational Site
Tucson, Arizona, United States, 85745
Pfizer Investigational Site
Tucson, Arizona, United States, 85712
Pfizer Investigational Site
Tucson, Arizona, United States, 85704
Pfizer Investigational Site
Tucson, Arizona, United States, 85710
United States, Colorado
Pfizer Investigational Site
Boulder, Colorado, United States, 80304
Pfizer Investigational Site
Colorado Springs, Colorado, United States, 80909
Pfizer Investigational Site
Denver, Colorado, United States, 80218
Pfizer Investigational Site
Fort Collins, Colorado, United States, 80528
Pfizer Investigational Site
Lakewood, Colorado, United States, 80228
Pfizer Investigational Site
Thornton, Colorado, United States, 80260
United States, Florida
Pfizer Investigational Site
Jacksonville, Florida, United States, 32207
Pfizer Investigational Site
Jacksonville, Florida, United States, 32204
Pfizer Investigational Site
Jacksonville Beach, Florida, United States, 32250
Pfizer Investigational Site
Ocala, Florida, United States, 34474
Pfizer Investigational Site
Orange Park, Florida, United States, 32073
United States, Indiana
Pfizer Investigational Site
Fishers, Indiana, United States, 46038
Pfizer Investigational Site
Fishers, Indiana, United States, 46037
Pfizer Investigational Site
Indianapolis, Indiana, United States, 46227
Pfizer Investigational Site
Indianapolis, Indiana, United States, IN 46219
Pfizer Investigational Site
Indianapolis, Indiana, United States, 46219
United States, Iowa
Pfizer Investigational Site
Cedar Rapids, Iowa, United States, 52403
United States, Massachusetts
Pfizer Investigational Site
Pittsfield, Massachusetts, United States, 01201
United States, New York
Pfizer Investigational Site
Albany, New York, United States, 12206
Pfizer Investigational Site
Latham, New York, United States, 12110-0610
United States, Oregon
Pfizer Investigational Site
Portland, Oregon, United States, 97227
Pfizer Investigational Site
Portland, Oregon, United States, 97225
United States, Texas
Pfizer Investigational Site
Arlington, Texas, United States, 76014-2084
Pfizer Investigational Site
Bedford, Texas, United States, 76022
Pfizer Investigational Site
Dallas, Texas, United States, 75231
Pfizer Investigational Site
Dallas, Texas, United States, 75246
Pfizer Investigational Site
Dallas, Texas, United States, 75230-2510
Pfizer Investigational Site
El Paso, Texas, United States, 79915
Pfizer Investigational Site
El Paso, Texas, United States, 79902
Pfizer Investigational Site
Garland, Texas, United States, 75042
Pfizer Investigational Site
Houston, Texas, United States, 77024
Pfizer Investigational Site
Houston, Texas, United States, 77029
Pfizer Investigational Site
Houston, Texas, United States, 77074
Pfizer Investigational Site
Houston, Texas, United States, 77030
Pfizer Investigational Site
Longview, Texas, United States, 75601
Pfizer Investigational Site
McAllen, Texas, United States, 78503
Pfizer Investigational Site
Mesquite, Texas, United States, 75150
Pfizer Investigational Site
Odessa, Texas, United States, 79761
Pfizer Investigational Site
Pasadena, Texas, United States, 77502
Pfizer Investigational Site
Plano, Texas, United States, 75075-7787
Pfizer Investigational Site
San Antonio, Texas, United States, 78217
Pfizer Investigational Site
Sherman, Texas, United States, 75090
Pfizer Investigational Site
Sugar Land, Texas, United States, 77479
Pfizer Investigational Site
Tyler, Texas, United States, 75702
Pfizer Investigational Site
Weslaco, Texas, United States, 78596
United States, Washington
Pfizer Investigational Site
Spokane, Washington, United States, 99218
Pfizer Investigational Site
Spokane, Washington, United States, 99202
Argentina
Pfizer Investigational Site
Haedo, Buenos Aires, Argentina, 1706
Pfizer Investigational Site
San Isidro, Buenos Aires, Argentina, 1642
Pfizer Investigational Site
San Martin, Buenos Aires, Argentina, 1650
Pfizer Investigational Site
Buenos Aires, Capital Federal, Argentina, 1417
Pfizer Investigational Site
Buenos Aires, Capital Federal, Argentina, 1406
Pfizer Investigational Site
Buenos Aires, Capital Federal, Argentina, 1425
Pfizer Investigational Site
Buenos Aires, Capital Federal, Argentina
Pfizer Investigational Site
Buenos Aires, Capital Federal, Argentina, 1426
Pfizer Investigational Site
Rosario 2000, Pcia. de Santa Fe, Argentina
Pfizer Investigational Site
Rosario, Santa Fe, Argentina, 2000
Pfizer Investigational Site
Capital Federal, Argentina, 1181
Pfizer Investigational Site
Cordoba, Argentina, 5000
Australia, New South Wales
Pfizer Investigational Site
Camperdown, New South Wales, Australia, 2050
Pfizer Investigational Site
Dubbo, New South Wales, Australia, 2830
Pfizer Investigational Site
Liverpool, New South Wales, Australia, 2170
Pfizer Investigational Site
Waratah, New South Wales, Australia, 2298
Australia, South Australia
Pfizer Investigational Site
Adelaide, South Australia, Australia, 5000
Australia, Victoria
Pfizer Investigational Site
Bendigo, Victoria, Australia, 3550
Pfizer Investigational Site
Box Hill, Victoria, Australia, 3128
Pfizer Investigational Site
Ringwood East, Victoria, Australia, 3135
Belgium
Pfizer Investigational Site
Antwerpen, Belgium, 2020
Pfizer Investigational Site
Arlon, Belgium, 6700
Pfizer Investigational Site
Baudour, Belgium, 7331
Pfizer Investigational Site
Brasschaat, Belgium, 2930
Pfizer Investigational Site
Bruxelles, Belgium, 1000
Pfizer Investigational Site
Bruxelles, Belgium, 1180
Pfizer Investigational Site
Charleroi, Belgium, 6000
Pfizer Investigational Site
Edegem, Belgium, 2650
Pfizer Investigational Site
Genk, Belgium, 3600
Pfizer Investigational Site
Haine St. Paul, Belgium, 7100
Pfizer Investigational Site
Hasselt, Belgium, 3500
Pfizer Investigational Site
Kraainem, Belgium, 1950
Pfizer Investigational Site
La Louviere, Belgium, 7100
Pfizer Investigational Site
Leuven, Belgium, 3000
Pfizer Investigational Site
Liege, Belgium, 4000
Pfizer Investigational Site
Merksem, Belgium, 2170
Pfizer Investigational Site
Namur, Belgium, 5000
Pfizer Investigational Site
Verviers, Belgium, 4800
Pfizer Investigational Site
Wilrijk, Belgium, 2610
Bosnia and Herzegovina
Pfizer Investigational Site
Sarajevo, Bosnia and Herzegovina, 71000
Bulgaria
Pfizer Investigational Site
Plovdiv, Bulgaria, 4004
Pfizer Investigational Site
Sofia, Bulgaria, 1504
Pfizer Investigational Site
Sofia, Bulgaria, 1784
Pfizer Investigational Site
Sofia, Bulgaria, 1756
Pfizer Investigational Site
Stara Zagora, Bulgaria, 6003
Croatia
Pfizer Investigational Site
Osijek, Croatia
Pfizer Investigational Site
Split, Croatia
Pfizer Investigational Site
Zagreb, Croatia, 10000
Pfizer Investigational Site
Zagreb, Croatia
Czech Republic
Pfizer Investigational Site
Brno, Czech Republic, 656 53
Pfizer Investigational Site
Ceske Budejovice, Czech Republic, 370 87
Pfizer Investigational Site
Prague 2, Czech Republic, 12808
Denmark
Pfizer Investigational Site
Aarhus C, Denmark, 8000
Pfizer Investigational Site
Esbjerg, Denmark, 6700
Pfizer Investigational Site
Herlev, Denmark, 2730
Pfizer Investigational Site
Herning, Denmark, 7400
Pfizer Investigational Site
Hilleroed, Denmark, 3400
Pfizer Investigational Site
Koebenhavn OE, Denmark, 2100
Pfizer Investigational Site
Naestved, Denmark, 4700
Pfizer Investigational Site
Roskilde, Denmark, 4000
Pfizer Investigational Site
Vejle, Denmark, 7100
Pfizer Investigational Site
Viborg, Denmark, 8800
Egypt
Pfizer Investigational Site
Cairo, Egypt
Estonia
Pfizer Investigational Site
Tartu, Estonia, 51014
France
Pfizer Investigational Site
Angers, France, 49033 Cedex 01
Pfizer Investigational Site
Annecy Cedex, France, 74011
Pfizer Investigational Site
Avignon Cedex 2, France, 84082
Pfizer Investigational Site
Bordeaux, France, 33300 Cedex
Pfizer Investigational Site
Bordeaux, France, 33030 Cedex
Pfizer Investigational Site
Brest, France, 29609 Cedex
Pfizer Investigational Site
Caen, France, 14052 Cedex
Pfizer Investigational Site
Caen Cedex 05, France, 14076
Pfizer Investigational Site
Clermont Ferrand, France, 63011
Pfizer Investigational Site
Evreux, France, 27000
Pfizer Investigational Site
Lagny Sur Marne, France, 77405 Cedex
Pfizer Investigational Site
Le Havre, France, 76600
Pfizer Investigational Site
Le Mans, France, 72000
Pfizer Investigational Site
Lille, France, 59020 Cedex
Pfizer Investigational Site
Lyon, France, 69373
Pfizer Investigational Site
Marseille, France, 13273
Pfizer Investigational Site
Meaux, France, 77100
Pfizer Investigational Site
Montbeliard, France, 25209 Cedex
Pfizer Investigational Site
Mulhouse, France, 68070 Cedex
Pfizer Investigational Site
Nice, France, 06189
Pfizer Investigational Site
Paris, France, 75248 Cedex 5
Pfizer Investigational Site
Paris, France, 75970 Cedex 20
Pfizer Investigational Site
Perpignan, France, 66046
Pfizer Investigational Site
Rennes, France, 35042
Pfizer Investigational Site
Rouen, France, 76038 Cedex
Pfizer Investigational Site
Saint-Herblain, France, 44805
Pfizer Investigational Site
St Cloud, France, 92210
Pfizer Investigational Site
Strasbourg, France, 67091 Cedex
Pfizer Investigational Site
Toulouse, France, 31502
Germany
Pfizer Investigational Site
Berlin, Germany, 13353
Pfizer Investigational Site
Berlin, Germany, 10117
Pfizer Investigational Site
Chemnitz, Germany, 09126
Pfizer Investigational Site
Erlangen, Germany, 91054
Pfizer Investigational Site
Freiburg, Germany, 79106
Pfizer Investigational Site
Gera, Germany, 07548
Pfizer Investigational Site
Greiz, Germany, 07973
Pfizer Investigational Site
Halle, Germany, 06120
Pfizer Investigational Site
Halle, Germany, 06110
Pfizer Investigational Site
Hamburg, Germany, 22081
Pfizer Investigational Site
Hildburghausen, Germany, 98646
Pfizer Investigational Site
Leipzig, Germany, 04129
Pfizer Investigational Site
Luebeck, Germany, 23538
Pfizer Investigational Site
Muenchen, Germany, 80335
Pfizer Investigational Site
Riesa, Germany, 01589
Pfizer Investigational Site
Rodewisch, Germany, 08228
Pfizer Investigational Site
Saarbruecken, Germany, 66113
Pfizer Investigational Site
Suhl, Germany, 98527
Pfizer Investigational Site
Weiden, Germany, 92637
Greece
Pfizer Investigational Site
Athens, Attiki, Greece, 115 28
Pfizer Investigational Site
Athens, Attiki, Greece, 115 22
Pfizer Investigational Site
Heraklion, Crete, Greece, 71 110
Hong Kong
Pfizer Investigational Site
New Territories, Hong Kong
Hungary
Pfizer Investigational Site
Budapest, Hungary, 1145
Pfizer Investigational Site
Budapest, Hungary, 1122
Pfizer Investigational Site
Budapest, Hungary, 1082
Ireland
Pfizer Investigational Site
Cork, Ireland
Pfizer Investigational Site
Cork, Ireland, Ireland
Pfizer Investigational Site
Dublin, Ireland
Pfizer Investigational Site
Dublin 9, Ireland
Pfizer Investigational Site
Galway, Ireland
Israel
Pfizer Investigational Site
Haifa, Israel, 34362
Pfizer Investigational Site
Haifa, Israel
Pfizer Investigational Site
Jerusalem, Israel, 91120
Pfizer Investigational Site
Jerusalem, Israel
Pfizer Investigational Site
Kfar Saba, Israel
Pfizer Investigational Site
Petah Tikva, Israel
Pfizer Investigational Site
Rehovot, Israel
Italy
Pfizer Investigational Site
Carpi, Modena, Italy, 41012
Pfizer Investigational Site
Alba (CN), Italy, 12051
Pfizer Investigational Site
Aviano (PN), Italy, 33081
Pfizer Investigational Site
Bergamo, Italy, 24128
Pfizer Investigational Site
Biella, Italy, 13900
Pfizer Investigational Site
Cagliari, Italy, 09121
Pfizer Investigational Site
Casale Monferrato, AL, Italy, 15033
Pfizer Investigational Site
Correggio, Italy, 42015
Pfizer Investigational Site
Cremona, Italy, 26100
Pfizer Investigational Site
Cuneo, Italy, 12100
Pfizer Investigational Site
Fermo FM, Italy, 63023
Pfizer Investigational Site
Firenze, Italy, 50134
Pfizer Investigational Site
Genova, Italy, 16132
Pfizer Investigational Site
Genova, Italy, 16128
Pfizer Investigational Site
Lecco, Italy, 23900
Pfizer Investigational Site
Lodi, Italy, 20075
Pfizer Investigational Site
Mantova, Italy, 46100
Pfizer Investigational Site
Milano, Italy, 20141
Pfizer Investigational Site
Milano, Italy, 20121
Pfizer Investigational Site
Milano, Italy, 21053
Pfizer Investigational Site
Milano, Italy, 20133
Pfizer Investigational Site
Modena, Italy, 41100
Pfizer Investigational Site
Monserrato (CA), Italy, 09042
Pfizer Investigational Site
Monza, Italy, 20052
Pfizer Investigational Site
Napoli, Italy, 80131
Pfizer Investigational Site
Palermo, Italy, 90139
Pfizer Investigational Site
Parma, Italy, 43100
Pfizer Investigational Site
Perugia, Italy, 06132
Pfizer Investigational Site
Piacenza, Italy, 29100
Pfizer Investigational Site
Pietra Ligure (SV), Italy, 17027
Pfizer Investigational Site
Pisa, Italy, 56100
Pfizer Investigational Site
Reggio Emilia, Italy, 42100
Pfizer Investigational Site
Roma, Italy, 00148
Pfizer Investigational Site
Sassari, Italy, 07100
Pfizer Investigational Site
Terni, Italy, 05100
Pfizer Investigational Site
Thiene (VI), Italy, 36016
Pfizer Investigational Site
Torino, Italy, 10126
Pfizer Investigational Site
Tortona, Italy, 15057
Pfizer Investigational Site
Trescore Balneario BG, Italy, 24069
Pfizer Investigational Site
Treviglio (BG), Italy, 24047
Pfizer Investigational Site
Varese, Italy, 21100
Luxembourg
Pfizer Investigational Site
Luxembourg, Luxembourg, 1210
Malta
Pfizer Investigational Site
Floriana, Malta, VLT 14
Netherlands
Pfizer Investigational Site
Amersfoort, Netherlands, 3818 ES
Pfizer Investigational Site
Amsterdam, Netherlands, 1066 CX
Pfizer Investigational Site
Amsterdam, Netherlands, 1061 AE
Pfizer Investigational Site
Amsterdam, Netherlands, 1105 AZ
Pfizer Investigational Site
Apeldoorn, Netherlands, 7300 DS
Pfizer Investigational Site
Blaricum, Netherlands, 1261 AN
Pfizer Investigational Site
Breda, Netherlands, 4818 CK
Pfizer Investigational Site
Delft, Netherlands, 2625 AD
Pfizer Investigational Site
Den Haag, Netherlands, 2545 CH
Pfizer Investigational Site
Eindhoven, Netherlands, 5623 EJ
Pfizer Investigational Site
Enschede, Netherlands, 7513 ER
Pfizer Investigational Site
Groningen, Netherlands, 9728 NZ
Pfizer Investigational Site
Groningen, Netherlands, 9700 RM
Pfizer Investigational Site
Hengelo, Netherlands, 7555 DL
Pfizer Investigational Site
Leeuwarden, Netherlands, 8934 AD
Pfizer Investigational Site
Leiden, Netherlands, 2333 ZA
Pfizer Investigational Site
Leidschendam, Netherlands, 2262 BA
Pfizer Investigational Site
Podybus 90153, Netherlands, 5200 ME Den Bosch
Pfizer Investigational Site
Roermond, Netherlands, 6043 CV
Pfizer Investigational Site
Sittard, Netherlands, 6131 BK
Pfizer Investigational Site
Utrecht, Netherlands, 3582 KE
Pfizer Investigational Site
Veldhoven, Netherlands, 5504 DB
Pfizer Investigational Site
Zaandam, Netherlands, 1502 DV
New Zealand
Pfizer Investigational Site
Auckland, New Zealand, 1023
Pfizer Investigational Site
Hamilton, New Zealand, 3240
Norway
Pfizer Investigational Site
Bergen, Norway, 5021
Pfizer Investigational Site
Bodo, Norway, 8092
Pfizer Investigational Site
Fredrikstad, Norway, 1603
Pfizer Investigational Site
Haugesund, Norway, 5390
Pfizer Investigational Site
Levanger, Norway, 7600
Pfizer Investigational Site
Mo i Rana, Norway, 8607
Pfizer Investigational Site
Molde, Norway, 6407
Pfizer Investigational Site
Notodden, Norway, 3674
Pfizer Investigational Site
Oslo, Norway
Pfizer Investigational Site
Rissa, Norway, 7100
Pfizer Investigational Site
Rjukan, Norway, 3660
Pfizer Investigational Site
Sandefjord, Norway
Pfizer Investigational Site
Tonsberg, Norway, 3103
Pfizer Investigational Site
Troms, Norway, 9038
Pfizer Investigational Site
Tromso, Norway, 9038
Peru
Pfizer Investigational Site
Lima, Peru, L34
Poland
Pfizer Investigational Site
Gdansk, Poland, 80-952
Pfizer Investigational Site
Gliwice, Poland, 44-101
Pfizer Investigational Site
Krakow, Poland, 31-826
Pfizer Investigational Site
Krakow, Poland, 31-115
Pfizer Investigational Site
Lodz, Poland, 93-509
Pfizer Investigational Site
Opole, Poland, 45-060
Pfizer Investigational Site
Poznan, Poland, 61-878
Pfizer Investigational Site
Sopot, Poland, 81-756
Pfizer Investigational Site
Warszawa, Poland, 02-781
Portugal
Pfizer Investigational Site
Coimbra, Portugal, 3040
Pfizer Investigational Site
Coimbra, Portugal
Pfizer Investigational Site
Evora, Portugal, 7000-811
Romania
Pfizer Investigational Site
Bucuresti, Romania, 72435
Pfizer Investigational Site
Cluj Napoca, Romania, 400015
Pfizer Investigational Site
Timisoara, Romania, 300223
Russian Federation
Pfizer Investigational Site
St. Petersburg, Russian Federation, 197758
Serbia
Pfizer Investigational Site
Belgrade, Serbia, 11000
Pfizer Investigational Site
Sremska Kamenica, Serbia, 21204
Slovakia
Pfizer Investigational Site
Banska Bystrica, Slovakia, 97517
Pfizer Investigational Site
Bratislava, Slovakia, SK-83310
Pfizer Investigational Site
Kosice, Slovakia, 041 90
Slovenia
Pfizer Investigational Site
Ljubljana, Slovenia, 1000
South Africa
Pfizer Investigational Site
Johannesburg, Gauteng, South Africa, 2196
Pfizer Investigational Site
Observatory, South Africa, 7925
Spain
Pfizer Investigational Site
Alcoy, Alicante, Spain, 03804
Pfizer Investigational Site
Elche, Alicante, Spain, 03203
Pfizer Investigational Site
San Juan de Alicante, Alicante, Spain, 03550
Pfizer Investigational Site
Sant Joan D'Alacant, Alicante, Spain, 03550
Pfizer Investigational Site
Badalona, Barcelona, Spain, 08911
Pfizer Investigational Site
Badalona, Barcelona, Spain, 08916
Pfizer Investigational Site
Terrassa, Barcelona, Spain, 08227
Pfizer Investigational Site
Terrassa, Barcelona, Spain, 08221
Pfizer Investigational Site
San Sebastian, Guipuzcoa, Spain, 20014
Pfizer Investigational Site
Barbastro, Huesca, Spain, 22300
Pfizer Investigational Site
Reus, Tarragona, Spain, 43201
Pfizer Investigational Site
Albacete, Spain, 02006
Pfizer Investigational Site
Alicante, Spain, 03010
Pfizer Investigational Site
Badajoz, Spain, 06080
Pfizer Investigational Site
Badajoz, Spain, 06008
Pfizer Investigational Site
Cordoba, Spain, 14004
Pfizer Investigational Site
Guadalajara, Spain, 19002
Pfizer Investigational Site
Lleida, Spain, 25198
Pfizer Investigational Site
Madrid, Spain, 28040
Pfizer Investigational Site
Madrid, Spain, 28041
Pfizer Investigational Site
Madrid, Spain, 28034
Pfizer Investigational Site
Valencia, Spain, 46014
Pfizer Investigational Site
Zaragoza, Spain, 50009
Sweden
Pfizer Investigational Site
Bor, Sweden, 50182
Pfizer Investigational Site
Boras, Sweden, 501 82
Pfizer Investigational Site
Goteborg, Sweden, 413 45
Pfizer Investigational Site
Halmstad, Sweden, 301 85
Pfizer Investigational Site
Helsingborg, Sweden, 251 87
Pfizer Investigational Site
Kristianstad, Sweden, 291 85
Pfizer Investigational Site
Linkoping, Sweden, 581 85
Pfizer Investigational Site
Lund, Sweden, 221 85
Pfizer Investigational Site
Malmo, Sweden, 205 02
Pfizer Investigational Site
Motala, Sweden, 591 85
Pfizer Investigational Site
Nassjo, Sweden, 575 81
Pfizer Investigational Site
Norrkoping, Sweden, 601 82
Pfizer Investigational Site
Varnamo, Sweden, 331 85
Pfizer Investigational Site
Vasteras, Sweden, 721 89
Pfizer Investigational Site
Vastervik, Sweden, 59381
Pfizer Investigational Site
Vaxjo, Sweden, 351 85
Switzerland
Pfizer Investigational Site
Basel, Switzerland, CH-4031
Pfizer Investigational Site
Bellinzona, Switzerland, CH-6500
Pfizer Investigational Site
Bern, Switzerland, 3010
Pfizer Investigational Site
Bern, Switzerland, CH-3012
Pfizer Investigational Site
Geneva, Switzerland, CH-1211
United Kingdom
Pfizer Investigational Site
Huntingdon, Cambs, United Kingdom, PE18 8NT
Pfizer Investigational Site
Bournemouth, Dorset, United Kingdom, BH7 7DW
Pfizer Investigational Site
Hull, East Yorkshire, United Kingdom, HU16 5JQ
Pfizer Investigational Site
Epping, Essex, United Kingdom, CM166TN
Pfizer Investigational Site
Westcliff-On-Sea, Essex, United Kingdom, SS0 0RY
Pfizer Investigational Site
Newport, Gwent, United Kingdom, NP6 2UB
Pfizer Investigational Site
Bangor, Gwynedd, United Kingdom, LL57 2PW
Pfizer Investigational Site
Salterhebble, Halifax, United Kingdom, HX6 0PW
Pfizer Investigational Site
Gosport, Hants, United Kingdom, PO12 2AA
Pfizer Investigational Site
Northwood, Middlesex, United Kingdom, HA6 2RN
Pfizer Investigational Site
Londonderry, N. Ireland, United Kingdom, BT47 1SB
Pfizer Investigational Site
Harrogate, N. Yorkshire, United Kingdom, HG2 7SX
Pfizer Investigational Site
Taunton, Somerset, United Kingdom, TA1 5DA
Pfizer Investigational Site
Swansea, South Wales, United Kingdom, SA2 8QA
Pfizer Investigational Site
York, Yorkshire, United Kingdom, Y03 7He
Pfizer Investigational Site
Belfast, United Kingdom, BT97AB
Pfizer Investigational Site
Bradford, United Kingdom, BD9 6RJ
Pfizer Investigational Site
Bristol, United Kingdom, BS10 5NB
Pfizer Investigational Site
Cardiff, United Kingdom, CF14 2TL
Pfizer Investigational Site
Coventry, United Kingdom, CV2 2DX
Pfizer Investigational Site
East Kilbride, United Kingdom, G75 8RG
Pfizer Investigational Site
Huddersfield, United Kingdom, HD3 3EA
Pfizer Investigational Site
Leeds, United Kingdom, LS1 3EX
Pfizer Investigational Site
Leeds, United Kingdom, LS9 7TF
Pfizer Investigational Site
Lincoln, United Kingdom
Pfizer Investigational Site
London, United Kingdom, W6 8RF
Pfizer Investigational Site
London, United Kingdom, N18 1QX
Pfizer Investigational Site
London, United Kingdom, SW17 0QT
Pfizer Investigational Site
London, United Kingdom, NW3 2QG
Pfizer Investigational Site
London, United Kingdom, N19 5NF
Pfizer Investigational Site
Luton, United Kingdom, LU4 0DZ
Pfizer Investigational Site
Manchester, United Kingdom, M20 4BX
Pfizer Investigational Site
Sheffield, United Kingdom, S10 2SJ
Pfizer Investigational Site
Shrewsbury, United Kingdom
Pfizer Investigational Site
Somerset, United Kingdom, BA21 4AT
Pfizer Investigational Site
Southampton, United Kingdom, S016 6YD
Pfizer Investigational Site
Steeton, United Kingdom, BD20 6TD
Pfizer Investigational Site
Stoke on Trent, United Kingdom, ST4 6QG
Pfizer Investigational Site
Telford, United Kingdom, TF1 6TF
Pfizer Investigational Site
Wythenshawe, Manchester, United Kingdom, M23 9LT
Sponsors and Collaborators
Pfizer
International Collaborative Cancer Group (ICCG)
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
No publications provided

Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT00038467     History of Changes
Other Study ID Numbers: 96-OEXE-031, A5991012
Study First Received: May 31, 2002
Last Updated: May 9, 2013
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases
Tamoxifen
Exemestane
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Therapeutic Uses
Pharmacologic Actions
Selective Estrogen Receptor Modulators
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Bone Density Conservation Agents
Estrogen Antagonists
Aromatase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on May 16, 2013